Senior Field Application Scientist, Light-based Bioprinting Specialist CELLINK
In this presentation, we will explore how bioprinting technologies address key challenges within drug discovery and drug screening. Bioprinting enables the creation of complex, heterogeneous structures that better mimic in vivo tissue. By precisely controlling the placement and composition of different cell types, scientists can create 3D biomimetic models with more realistic cell-cell interactions, gradients, and microenvironments. Standardized workflows can be developed, reducing time-consuming and repetitive tasks, and enabling more consistent data gathering. Join us to learn about the exciting potential of bioprinting technology in advancing disease modeling and drug discovery.